Prenetics Global Limited (PRE)
NASDAQ: PRE · Real-Time Price · USD
21.10
+0.92 (4.56%)
At close: May 29, 2026, 4:00 PM EDT
21.50
+0.40 (1.90%)
After-hours: May 29, 2026, 7:32 PM EDT
Company Description
Prenetics Global Limited, a health sciences company, focuses on consumer health in Hong Kong and the United States.
It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand.
The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide insights into health, wellness, and genetic predispositions.
Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Prenetics Global Limited
| Country | Hong Kong |
| Founded | 2014 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 98 |
| CEO | Sheng Wu Yeung |
Contact Details
Address: Unit 703-706, K11 Atelier King’s Road, 728 King’s Road Quarry Bay Hong Kong | |
| Phone | 852 2210 9588 |
| Website | prenetics.com |
Stock Details
| Ticker Symbol | PRE |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001876431 |
| CUSIP Number | G72245106 |
| ISIN Number | KYG722451229 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Samantha Kwok | Chief of Staff to Group Chief Executive Officer and Vice President of People & Operations |
| Sheng Wu Yeung | Co-Founder, Chairperson and Chief Executive Officer |
| Brian J. Rosin | Chief Financial Officer |
| Dr. Senthil Kumar Sundaram M.D. | Chief Clinical Officer |
| David Eric Vanderveen | President of Americas and Executive Director |
| Dr. James DiNicolantonio | Chief Nutrition Officer, Member of Scientific and Medical Advisory Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 20, 2026 | 6-K | Report of foreign issuer |
| May 14, 2026 | 6-K | Report of foreign issuer |
| May 14, 2026 | 6-K | Report of foreign issuer |
| May 7, 2026 | 6-K | Report of foreign issuer |
| May 4, 2026 | 6-K | Report of foreign issuer |
| Apr 30, 2026 | 20-F | Annual and transition report of foreign private issuers |
| Apr 22, 2026 | SCHEDULE 13G/A | Filing |
| Apr 2, 2026 | 6-K | Report of foreign issuer |
| Mar 31, 2026 | F-3 | Filing |
| Mar 6, 2026 | 6-K | Report of foreign issuer |